News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Lockshin Curtis
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/22/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2022 |
4
| Lockshin Curtis (Chief Sciencific Officer) has filed a Form 4 on Xenetic Biosciences, Inc.|
Txns:
| Granted 50,000 options
@ $1.12, valued at
$56k
|
|
| 02/16/2022 |
4
| Lockshin Curtis (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 03/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Lockshin Curtis (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 12/06/2019 |
4
| Lockshin Curtis (Chief Scientific Officer) has filed a Form 4 on Xenetic Biosciences, Inc.|
Txns:
| Granted 90,000 options
@ $1.31, valued at
$117.9k
|
|
| 02/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2018 |
4
| Lockshin Curtis (Director) has filed a Form 4 on RXi Pharmaceuticals Corp|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 02/03/2017 |
4
| Lockshin Curtis (Director) has filed a Form 4 on RXi Pharmaceuticals Corp |
| 01/06/2017 |
3
| Lockshin Curtis (Chief Scientific Officer) has filed a Form 3 on Xenetic Biosciences, Inc. |
| 02/12/2016 |
4
| Lockshin Curtis (Director) has filed a Form 4 on RXi Pharmaceuticals Corp|
Txns:
| Granted 16,666 options to buy
@ $0.2858, valued at
$4.8k
|
|
| 06/03/2015 |
4
| Lockshin Curtis (Director) has filed a Form 4 on RXi Pharmaceuticals Corp|
Txns:
| Granted 12,000 shares
@ $0.4, valued at
$4.8k
Granted 6,000 options to buy
@ $0.455, valued at
$2.7k
Granted 6,000 warrants
@ $0.52, valued at
$3.1k
|
|
| 06/02/2015 |
4
| Lockshin Curtis (Director) has filed a Form 4 on RXi Pharmaceuticals Corp|
Txns:
| Granted 16,666 options to buy
@ $0.38, valued at
$6.3k
|
|
| 06/04/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/30/2013 |
4
| Lockshin Curtis (Director) has filed a Form 4 on RXi Pharmaceuticals Corp|
Txns:
| Bought 1,000 shares
@ $3.7, valued at
$3.7k
|
|
| 05/03/2013 |
4/A
| Lockshin Curtis (Director) has filed a Form 4 on RXi Pharmaceuticals Corp|
Txns:
| Granted 1,000,000 options to buy
@ $0.2395, valued at
$239.5k
|
|
| 04/22/2013 |
4
| Lockshin Curtis (Director) has filed a Form 4 on RXi Pharmaceuticals Corp|
Txns:
| Granted 1,000,000 options to buy
@ $0.2395, valued at
$239.5k
|
|
| 04/22/2013 |
3
| Lockshin Curtis (Director) has filed a Form 3 on RXi Pharmaceuticals Corp |
| 12/26/2012 |
4
| Lockshin Curtis (Director) has filed a Form 4 on ChromaDex Corp.|
Txns:
| Disposed/sold 67,500 options to buy
@ $1.54, valued at
$104k
Granted 45,651 options to buy
@ $0.945, valued at
$43.1k
|
|
| 09/26/2012 |
4
| Lockshin Curtis (Director) has filed a Form 4 on ChromaDex Corp.|
Txns:
| Granted 67,500 options to buy
@ $0.64, valued at
$43.2k
|
|
| 07/20/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/12/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/30/2010 |
4
| Lockshin Curtis (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 35,000 options to buy
@ $0.14, valued at
$4.9k
|
|
| 02/26/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/01/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/22/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|